Back
Genmab AS Stock Predictions
Sponsored
GMAB
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Sell
20
GMAB
Genmab AS
Last Price:
26.48
Seasonality Move:
6.18%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly optionsGenmab AS Stock Forecast
- Over the next 52 weeks, Genmab AS has on average historically risen by 28.4% based on the past 11 years of stock performance.
- Genmab AS has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
-
Is Genmab AS Stock Undervalued?
The current Genmab AS [GMAB] share price is $26.20. The Score for GMAB is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - GMAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Genmab AS Stock Go Up Next Year?
- Over the next 52 weeks, Genmab AS has on average historically risen by 28.4% based on the past 11 years of stock performance.
Genmab AS Stock Rating
Sell
20
Genmab AS (GMAB)
is a Sell
Is Genmab AS overpriced?
- Genmab AS has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
Genmab AS Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com
52-Week Data
52-Week High:
37.97
52-Week Low:
24.53
Prediction Charts
Market Cap:
16.64B
Price in USD:
26.20
Volume:
433.15K
Beta:
0.71
Technical Analysis
SMA50:
27.25
SMA100:
27.45
SMA200:
28.62
52-Wk Change:
-29.93%
Stock Predictions
-
Is Genmab AS stock public?
Yes, Genmab AS is a publicly traded company. -
What is the Genmab AS stock quote today?
The Genmab AS stock price is 26.20 USD today. -
How to buy Genmab AS stock online?
You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 27.84 | 27.81 | 27.93 | 27.74 |
Aug-30 | 27.72 | 27.80 | 27.86 | 27.62 |
Sep-3 | 27.73 | 27.42 | 27.81 | 27.38 |
Sep-4 | 27.43 | 27.59 | 27.73 | 27.42 |
Sep-5 | 27.80 | 27.71 | 27.82 | 27.54 |
Sep-6 | 27.82 | 27.50 | 27.91 | 27.46 |
Sep-9 | 27.39 | 27.46 | 27.62 | 27.34 |
Sep-10 | 27.62 | 27.50 | 27.62 | 27.38 |
Sep-11 | 27.15 | 26.94 | 27.18 | 26.68 |
Sep-12 | 26.66 | 26.48 | 26.71 | 26.28 |
Sep-13 | 26.55 | 26.90 | 26.90 | 26.55 |
Sep-16 | 26.75 | 26.58 | 26.77 | 26.39 |
Sep-17 | 26.54 | 26.43 | 26.59 | 26.36 |
Sep-18 | 26.31 | 26.20 | 26.57 | 26.10 |
Genmab AS Earnings
Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Genmab AS Forecast Revenue Growth
Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.10 per share, an increase this year of $0.15 per share, and an increase next year of $0.33 per share.
* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.